CRTAM在快速性抗结核免疫应答和杀菌性免疫保护过程中的作用及机制
批准号:
32070943
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
沈洪波
依托单位:
学科分类:
感染与非感染性炎症
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
沈洪波
中文摘要
目前宿主抗结核杆菌(Mtb)感染的有效保护性免疫应答尚未阐明。结核感染抗性人群是与结核病(TB)患者密切接触但无感染特征的群体,能快速清除感染的Mtb,是探究有效保护性免疫的最适人群。预实验发现CRTAM在结核感染抗性人群外周血向肺部迁移的效应细胞中高表达,CRTAM+CD107a+CD3+细胞可有效杀灭巨噬细胞内Mtb。据此推测CRTAM在宿主快速清除结核感染过程中发挥重要作用。本研究拟阐明结核抗原反应性CRTAM+CD107a+CD3+细胞在结核感染抗性人群中的特异表型及功能特征,证实CRTAM与固有免疫类T细胞发挥快速性效应功能相关;通过功能性单细胞测序等技术阐明CRTAM+CD107a+CD3+抗结核感染机制;利用基因敲除小鼠等证实CRTAM及CRTAM-Necl2信号轴在抗结核感染中的作用;阐明CRTAM在TB体内功能受损的机制。本研究有助于揭示宿主抗结核有效保护性免疫新机制。
英文摘要
The occurrence and development of tuberculosis (TB) are determined by effective protective immunity in humans after Mycobacteria tuberculosis (Mtb) infection. However, it is unclear what is the protective immune response to Mtb infection? Resisters are special human subjects who repeatedly expose to sputum Mtb positive TB patients but remain uninfected, might rapidly clear Mtb in early stage infection. So, Resisters are the best human subjects used to explore the protective immune response to Mtb infection. In the previous studies, we have found that CRTAM highly expressed in effector cells expressing chemokine markers in blood of Resisters after PPD inoculation. The CRTAM+CD107a+CD3+ T cells isolated from blood of Resisters with induction of Mtb antigen could effectively inhibit Mtb growth in macrophages. So, we hypothesized that the CRTAM and its related signal pathway play important roles in rapid clearance of Mtb infection in early stage in humans. To test this hypothesis and elucidate immune mechanisms, we will conduct the following interrelated studies: Characterizing the specific phenotypes and functions of CRTAM+CD107a+CD3+ cells in Resisters by comparing with other subjects including TB patients, latent tuberculosis infected subjects and healthy controls; Verifying the correlation between CRTAM expression and the rapid response function of innate-like T cells in Resisters; Exploring the mechanisms of CTRAM+CD107a+CD3+ cells against Mtb infection by functional single cell sequencing and other methods; Determining that CRTAM and the CRTAM-Necl2 signal axis play protective roles in immune response against Mtb infection using the CRTAM or Necl2 knock-out mice comparing to wild type mice; And clarifying the dysfunction of CRTAM in TB patients. Findings will prove that CRTAM related signal pathway may contribute to the mechanism for sterilizing immunity against TB, and provide new concepts and protective mechanisms of anti-TB immune response.
本项目团队发现在结核感染抗性人群外周血向肺部迁移的效应细胞(CXCR3+CD107a+)中CRTAM(又称CD355)高水平表达。本项目中,证实在活化的T细胞其中包括具有固有免疫特征的γδ T、iNKT中,CRTAM的表达量显著升高;而且结核病患者的淋巴细胞中CRTAM的表达量显著降低。为探究CRTAM的作用机制,分选CRTAM+与CRTAM-的T细胞进行转录组分析,发现CRTAM+细胞中上调的差异基因功能与细胞毒作用等相关。接下来,通过gain of function/loss of function改变CRTAM表达量检测T细胞效应功能的变化,发现当使用CRTAM激活抗体以及外源CRTAM重组蛋白处理时,T细胞杀菌作用增强;当通过表达shRNA的慢病毒降低其表达量时,细胞杀菌功能减弱,流式检测发现淋巴细胞分泌IFNγ、TNFα等的能力下降。利用CRTAM编码基因敲除小鼠模型进行感染实验,发现在BCG和H37Rv感染1周和2周时,CRTAM基因敲除小鼠的脾和肺脏器内菌落数目明显高于野生对照小鼠组,说明CRTAM在感染早期能够抑制结核杆菌的生长,参与体内的抗结核功能。CADM1(NECL2)是目前已知的CRTAM的结合配体,参与胞内信号调节。外源CRTAM重组蛋白处理巨噬细胞时,CADM1表达量升高,提示CRTAM-CADM1信号轴可能调控细胞的效应功能。通过慢病毒构建CADM1过表达以及敲低的THP1稳转株,发现CADM1过表达增强了巨噬细胞的杀菌作用;CADM1表达减弱时,巨噬细胞杀菌功能被抑制;转录组分析发现CADM1可能调控PI3K信号通路。而且CADM1表达增强时,刺激PBMC产生IFNγ、TNFα等功能性细胞因子的能力也增强。通过本研究,我们发现CRTAM-CADM1信号轴在抗结核免疫中的发挥重要作用。
分泌颗粒溶素granulysin的T细胞在抗结核杆菌感染免疫应答中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:沈洪波
-
依托单位:
国内基金
海外基金